USP11 and hepatocellular carcinoma: Furthermore, Heeyoung Yang et al. [30] identified that USP11 promotes the proliferation, tumorigenesis, and sorafenib-resistance of hepatocellular carcinoma via negatively regulating KLF4, which was known as a tumor suppressor factor in previous researches.